Panacea Biotech to produce 25 million doses of Sputnik V corona vaccine
Indian vaccine producer Panacea Biotech has signed a licensing deal for producing 25 million doses of the Sputnik V corona vaccine. The company has entered into an agreement with Human Vaccine Limited Liability Company, a Russian Direct Investment Fund (RDIF) subsidiary, Generium Joint Stock Company, and Dr. Reddy’s Laboratories. Under the terms of the agreement, […]